Drug recall · May 13, 2015
ULTRA ZX DIETARY SUPPLEMENT recall
Why: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
ULTRA ZX DIETARY SUPPLEMENT (Extracto de Naranjo Amargo 70, Extracto de semilla de Sen 47.6, Lagrima de Coix 42, Almidon Medico 84), 30 capsule bottles, Manufactured and distributed by: Ultra ZX Labs, L.L.C. 2525 SW 3rd Ave Apt 1704 Miami, Florida 33129-2068.
- Lots / codes
All lots/codes/bottles/packages.
- Quantity
- 636 bottles
- Company
- Ultra ZX Supplements, Miami, FL
- Distribution
- Nationwide and Puerto Rico Foreign: Spain and Ecuador
- Initiated
- March 10, 2015 · Voluntary: Firm initiated
- Classified
- May 5, 2015
- Reported
- May 13, 2015
- Ended
- April 26, 2018
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.